Holt Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Holt Capital Partners's LLY Position: Q2 2026 in Review
Holt Capital Partners increased its Eli Lilly (LLY) stake by 16% in Q2 2026, buying an estimated $313K and bringing the position to 2,258 shares worth $2.71M. The position accounts for 0.32% of the portfolio, ranked #54.
Holt Capital Partners first reported a position in LLY in Q4 2014 and has held it in 20 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Holt Capital Partners held 2,258 shares of Eli Lilly worth $2.71M as of Q2 2026.
- Holt Capital Partners bought 306 Eli Lilly shares in Q2 2026, an estimated $313K.
- Eli Lilly made up 0.32% of Holt Capital Partners's portfolio in Q2 2026, its #54 holding.
- Holt Capital Partners first reported a position in Eli Lilly in Q4 2014 and has held it in 20 quarters since.
- 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Holt Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.